arrow
M

Monika A. Davare

oregon health & science university
H指数:38
被引数:6,344

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations (vol 4, pg 1345, 2023)
2023-10-091
OAAI
Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations
2023-09-2111
OAAI
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations

NVL-520是ROS1融合和继发性耐药突变的选择性,TRK保留和脑渗透抑制剂

2022-12-1319
OAAI
RET inhibition in novel patient-derived models of RET fusion-positive lung adenocarcinoma reveals a role for MYC upregulation

RET融合阳性肺腺癌的新型患者衍生模型中的RET抑制揭示了MYC上调的作用

2021-02-1112
OAAI
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion-Positive Lung Cancer by Combining Selpercatinib with Crizotinib
2021-01-0495
OAAI